Literature DB >> 8513497

Constitutive activation of Src family kinases in mouse embryos that lack Csk.

S Nada1, T Yagi, H Takeda, T Tokunaga, H Nakagawa, Y Ikawa, M Okada, S Aizawa.   

Abstract

Csk is a novel cytoplasmic protein-tyrosine kinase that has been shown to inactivate members of the Src family of protein-tyrosine kinases in vitro. To examine the function of Csk in vivo, Csk-deficient mouse embryos were generated by gene targeting in embryonic stem cells. These embryos were developmentally arrested at the 10 to 12 somite stage and exhibited growth retardation and necrosis in the neural tissues. The kinase activity of p60c-src, p59fyn, and p53/56lyn in these embryos was greatly enhanced as an apparent consequence of enhanced specific activity. The increase in kinase activity was associated with an increase in tyrosine phosphorylation of several proteins, especially those around 85 and 120 kd. Thus, these results suggest that Csk indeed acts as an indispensable negative regulator of Src family kinases in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513497     DOI: 10.1016/0092-8674(93)90642-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  133 in total

1.  Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination.

Authors:  H Oda; S Kumar; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Ubiquitin-mediated degradation of active Src tyrosine kinase.

Authors:  K F Harris; I Shoji; E M Cooper; S Kumar; H Oda; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.

Authors:  B Wang; S Lemay; S Tsai; A Veillette
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Sequential requirements of the N-terminal palmitoylation site and SH2 domain of Src family kinases in the initiation and progression of FcepsilonRI signaling.

Authors:  Z i Honda; T Suzuki; H Kono; M Okada; T Yamamoto; C Ra; Y Morita; K Yamamoto
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

Authors:  C E Andoniou; N L Lill; C B Thien; M L Lupher; S Ota; D D Bowtell; R M Scaife; W Y Langdon; H Band
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  Src family kinases are required for integrin but not PDGFR signal transduction.

Authors:  R A Klinghoffer; C Sachsenmaier; J A Cooper; P Soriano
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

Review 7.  Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases.

Authors:  Michelle L Hermiston; Zheng Xu; Ravindra Majeti; Arthur Weiss
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 8.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

9.  Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.

Authors:  Anjali Teckchandani; George S Laszlo; Sergi Simó; Khyati Shah; Carissa Pilling; Alexander A Strait; Jonathan A Cooper
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

10.  Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.

Authors:  Souad Rahmouni; Torkel Vang; Andres Alonso; Scott Williams; Marianne van Stipdonk; Chiara Soncini; Michel Moutschen; Stephen P Schoenberger; Tomas Mustelin
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.